A New Chapter in Parkinson’s Therapy: iPS‑Cell‑Derived Dopaminergic Cells Show Safety & Promise
A pioneering clinical trial has marked a major milestone in regenerative medicine for Parkinson’s disease (PD). Published in Nature in May 2025, the Phase I/II study led by Sawamoto, Doi, Takahashi and colleagues demonstrated that transplantation of dopamine‑producing neurons derived from induced pluripotent stem (iPS) cells is safe, well tolerated, and potentially effective in a […]